Stock listing
Lang & Schwarz:A412BH Aclarion, Inc. Aktie
German listing (Lang & Schwarz) of Aclarion, Inc. · home listing NASDAQ:ACON
Follow Aclarion, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:ACON
$1.22 USD -0.12 (-8.8%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ACON
- Day range
- $1.22 – $1.38 USDNov 20, 2026
- Volume
- 44,731 sharesNov 20, 2026
- Market cap
- $3.52M USDAt the close on Nov 20, 2026 · price × 2.88M shares outstanding
- 52-week range
- $1.22 – $9.36 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $83,843 USDMedian day 20,264 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ACON · Home | $1.222 USD | -0.118 (-8.8%) | 44,731 | $1.356 | $1.38 | $1.22 | $1.34 | Close on Nov 20, 2026 |
| Frankfurt:IT20 | €1.01 EUR | -0.12 (-10.6%) | — | €1.20 | €1.20 | €1.01 | €1.13 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:ACON · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.222 | -0.118 | -8.8% | $1.356 | $1.38 | $1.22 | 44,731 | |
| $1.34 | -0.03 | -2.2% | $1.38 | $1.38 | $1.335 | 7,381 | |
| $1.37 | -0.02 | -1.4% | $1.37 | $1.42 | $1.35 | 9,747 | |
| $1.39 | -0.17 | -10.9% | $1.56 | $1.57 | $1.35 | 22,486 | |
| $1.56 | -0.03 | -1.9% | $1.63 | $1.63 | $1.557 | 10,525 | |
| $1.59 | -0.04 | -2.5% | $1.605 | $1.652 | $1.57 | 18,934 | |
| $1.63 | +0.03 | +1.9% | $1.64 | $1.66 | $1.54 | 26,862 | |
| $1.60 | -0.15 | -8.6% | $1.75 | $1.75 | $1.60 | 12,219 | |
| $1.75 | +0.09 | +5.4% | $1.68 | $1.79 | $1.675 | 24,342 | |
| $1.66 | +0.10 | +6.4% | $1.638 | $1.68 | $1.61 | 15,270 | |
| $1.56 | -0.18 | -10.3% | $1.74 | $1.74 | $1.544 | 14,128 | |
| $1.74 | -0.02 | -1.1% | $1.78 | $1.78 | $1.721 | 10,643 | |
| $1.76 | -0.04 | -2.2% | $1.754 | $1.789 | $1.71 | 20,264 | |
| $1.80 | -0.15 | -7.7% | $1.92 | $1.94 | $1.80 | 17,108 | |
| $1.95 | -0.02 | -1.0% | $2.00 | $2.00 | $1.89 | 18,124 | |
| $1.97 | -0.07 | -3.4% | $2.021 | $2.021 | $1.92 | 15,274 | |
| $2.04 | +0.12 | +6.3% | $1.95 | $2.055 | $1.95 | 12,449 | |
| $1.92 | -0.01 | -0.5% | $1.95 | $1.965 | $1.92 | 2,503 | |
| $1.93 | 0.00 | 0.0% | $1.93 | $1.98 | $1.92 | 18,708 | |
| $1.93 | -0.005 | -0.3% | $1.88 | $1.97 | $1.88 | 10,069 | |
| $1.935 | -0.015 | -0.8% | $1.939 | $1.99 | $1.90 | 15,045 | |
| $1.95 | -0.02 | -1.0% | $1.945 | $1.963 | $1.92 | 10,242 | |
| $1.97 | +0.08 | +4.2% | $1.90 | $2.00 | $1.882 | 17,002 | |
| $1.89 | +0.04 | +2.2% | $1.86 | $1.94 | $1.85 | 13,658 | |
| $1.85 | -0.103 | -5.3% | $1.87 | $1.94 | $1.85 | 11,599 | |
| $1.953 | +0.013 | +0.7% | $1.90 | $2.02 | $1.90 | 7,236 | |
| $1.94 | -0.20 | -9.3% | $2.14 | $2.14 | $1.89 | 70,971 | |
| $2.14 | -0.105 | -4.7% | $2.25 | $2.25 | $2.091 | 21,361 | |
| $2.245 | -0.095 | -4.1% | $2.341 | $2.35 | $2.22 | 26,982 | |
| $2.34 | +0.03 | +1.3% | $2.32 | $2.365 | $2.32 | 7,297 | |
| $2.31 | -0.04 | -1.7% | $2.36 | $2.41 | $2.30 | 31,604 | |
| $2.35 | +0.06 | +2.6% | $2.32 | $2.39 | $2.32 | 10,416 | |
| $2.29 | -0.05 | -2.1% | $2.351 | $2.36 | $2.28 | 30,912 | |
| $2.34 | -0.04 | -1.7% | $2.35 | $2.395 | $2.33 | 33,181 | |
| $2.38 | -0.06 | -2.5% | $2.475 | $2.475 | $2.35 | 15,749 | |
| $2.44 | +0.03 | +1.2% | $2.45 | $2.499 | $2.43 | 7,146 | |
| $2.41 | +0.03 | +1.3% | $2.44 | $2.46 | $2.40 | 18,715 | |
| $2.38 | -0.06 | -2.5% | $2.48 | $2.60 | $2.32 | 79,569 | |
| $2.44 | -0.15 | -5.8% | $2.645 | $2.72 | $2.39 | 75,466 | |
| $2.59 | -0.04 | -1.5% | $2.63 | $2.715 | $2.58 | 30,137 | |
| $2.63 | -0.31 | -10.5% | $2.605 | $2.68 | $2.55 | 61,389 | |
| $2.94 | +0.31 | +11.8% | $2.565 | $2.96 | $2.56 | 309,151 | |
| $2.63 | +0.17 | +6.9% | $2.52 | $2.64 | $2.48 | 33,928 | |
| $2.46 | -0.06 | -2.4% | $2.47 | $2.52 | $2.46 | 12,410 | |
| $2.52 | -0.12 | -4.5% | $2.59 | $2.64 | $2.472 | 15,734 | |
| $2.64 | +0.09 | +3.5% | $2.52 | $2.64 | $2.41 | 35,000 | |
| $2.55 | -0.07 | -2.7% | $2.60 | $2.62 | $2.51 | 23,122 | |
| $2.62 | +0.04 | +1.6% | $2.54 | $2.62 | $2.524 | 9,545 | |
| $2.58 | -0.02 | -0.8% | $2.63 | $2.63 | $2.511 | 13,604 | |
| $2.60 | +0.06 | +2.4% | $2.57 | $2.64 | $2.55 | 17,848 | |
| $2.54 | +0.12 | +5.0% | $2.465 | $2.60 | $2.40 | 85,206 | |
| $2.42 | -0.02 | -0.8% | $2.40 | $2.45 | $2.316 | 13,080 | |
| $2.44 | +0.09 | +3.8% | $2.34 | $2.53 | $2.34 | 61,148 | |
| $2.35 | +0.06 | +2.6% | $2.261 | $2.41 | $2.26 | 44,099 | |
| $2.29 | -0.02 | -0.9% | $2.27 | $2.32 | $2.251 | 46,485 | |
| $2.31 | -0.02 | -0.9% | $2.325 | $2.42 | $2.25 | 63,706 | |
| $2.33 | -0.02 | -0.9% | $2.38 | $2.38 | $2.26 | 40,488 | |
| $2.35 | -0.05 | -2.1% | $2.40 | $2.40 | $2.31 | 37,128 | |
| $2.40 | -0.12 | -4.8% | $2.52 | $2.52 | $2.35 | 35,254 | |
| $2.52 | +0.13 | +5.4% | $2.37 | $2.52 | $2.31 | 54,077 | |
| $2.39 | -0.10 | -4.0% | $2.46 | $2.46 | $2.32 | 103,616 | |
| $2.49 | -0.17 | -6.4% | $2.65 | $2.65 | $2.43 | 175,091 | |
| $2.66 | -0.05 | -1.8% | $2.73 | $2.73 | $2.61 | 49,046 | |
| $2.71 | +0.02 | +0.7% | $2.75 | $2.83 | $2.58 | 44,412 | |
| $2.69 | -0.08 | -2.9% | $2.76 | $2.76 | $2.64 | 45,720 |
Splits
3 splits since 2024 · NASDAQ:ACON · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-27 | Consolidation | |
| 1-for-335 | Consolidation | |
| 1-for-16 | Consolidation |
- Ticker
- Lang & Schwarz:A412BH
- Asset type
- Stock
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news
Aclarion Announces New Real-World Publication: Nociscan® Validated by Strong Agreement with Discography in Diagnosing Painful Lumbar Discs
Oct 22, 2026
Closed $1.94 (-0.8%) on Oct 22, 2026
Aclarion Publishes CEO Shareholder Letter Highlighting Continued Scan Volume Growth and Advancing Clinical Program in Third Quarter 2026
Oct 20, 2026
Closed $1.97 (+4.2%) on Oct 20, 2026
Aclarion to Present at the 20th Annual LD Micro Main Event
Oct 13, 2026
Closed $2.14 (-4.7%) on Oct 13, 2026
Aclarion Broadens CLARITY Trial Enrollment Criteria to Accelerate Enrollment
Oct 8, 2026
Closed $2.31 (-1.7%) on Oct 8, 2026
Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites
Sep 29, 2026
Closed $2.38 (-2.5%) on Sep 29, 2026
Aclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology
Aug 4, 2026
Closed $2.38 (+0.8%) on Aug 4, 2026
Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026
Jul 29, 2026
Closed $2.02 (-5.4%) on Jul 29, 2026
Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice
Jul 21, 2026
Closed $2.54 (-3.4%) on Jul 21, 2026
Aclarion Announces Texas Spine Care Center as New CLARITY Site
Jul 7, 2026
Closed $2.99 (-2.6%) on Jul 7, 2026
Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub
Jun 10, 2026
Closed $3.17 (-2.9%) on Jun 10, 2026
Aclarion, Inc. on 6ix
- News releases
- 38 in the last 12 months · 124 in all · newest Oct 22, 2026 · oldest 2022
- Decks
- 3 decks · latest Apr 23, 2025
Where Aclarion, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ACON · Home listing | NASDAQ | United States | USD |
| LS Exchange:A412BH | LS Exchange | Germany | EUR |
| BOATS:ACON | BOATS | United States | USD |
| Frankfurt:IT20 | Frankfurt | Germany | EUR |
| Lang & Schwarz:A412BH · This page | Lang & Schwarz | Germany | EUR |
Valuation
Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- −$10.66M USD
- P/E
- Loss
- EV/sales
- −108×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.2×
- Gross margin
- 29.0%
- Operating margin
- Revenue too small
- Net margin
- Revenue too small
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 1.30
Forecasts
1 strong buy · Analysts' consensus from EODHD, read Nov 13, 2026. Not 6ix's view and not investment advice.
- Price target
- 7.63 USD · Analysts' mean
- EPS, year to Dec 2026
- -4.51 · 1 analyst
- Revenue, year to Dec 2026
- 109.5K · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| Brent Ness | Chief Executive Officer, President, and Director |
| Greg Gould | Chief Financial Officer |
| Amanda Williams | SVP, Clinical and Regulatory at Cordis |
| Bill Wesemann | Director, LivePerson Inc., Stationhead Inc., Mylio Inc. |
| Daniel Keefe | Commercial Director, Western U |
| Jason Brosniak | Commercial Director |
| Jeff Thramann | Executive Director, Executive Chairman, and Director |
| Ryan Bond | Chief Strategy Officer |
Board
| Director | Role |
|---|---|
| Jeff Thramann | Executive Director, Executive Chairman, and Director |
| Brent Ness | Chief Executive Officer, President, and Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 11, 2026 · After close | −2.5% |
| Q2 2026 | Aug 6, 2026 · Before open | −0.4% |
| Q1 2026 | May 13, 2026 · After close | −1.8% |
| Q4 2025 | Feb 25, 2026 | +6.3% |
| Q3 2025 | Nov 12, 2025 · Before open | −3.4% |
| Q2 2025 | Aug 14, 2025 · After close | +2.2% |
| Q1 2025 | May 15, 2025 | −3.1% |
| Q4 2024 | Feb 26, 2025 | −18.6% |
| Q3 2024 | Nov 14, 2024 · After close | −4.1% |
| Q2 2024 | Aug 14, 2024 · After close | +10.6% |
All 19 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 15, 2024 · After close | +18.0% |
| Q4 2023 | Feb 20, 2024 · After close | −7.2% |
| Q3 2023 | Nov 14, 2023 · After close | −7.3% |
| Q2 2023 | Aug 25, 2023 · After close | 0.0% |
| Q1 2023 | May 31, 2023 | −1.9% |
| Q4 2022 | Feb 27, 2023 · After close | +0.1% |
| Q3 2022 | Nov 14, 2022 · Before open | −3.0% |
| Q2 2022 | Aug 15, 2022 · Before open | +2.3% |
| Q1 2022 | Jun 6, 2022 · After close | −1.9% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (April 2025) | Investor deck | 22 slides | Apr 23, 2025 |
| Investor Presentation (September 2023) | Investor deck | 26 slides | Sep 28, 2023 |
| Investor Presentation (October 2022) | Investor deck | 21 slides | Oct 25, 2022 |
Financings
| Raise | Date |
|---|---|
| Common stock Closed: US$10.4M raised · US$5.18 a share · Dawson James Securities, Inc. Dealers: Dawson James Securities, Inc. (lead) | Jan 13, 2026 |
| Registered direct offering of common stock Closed: US$2.5M raised | Oct 14, 2025 |
| Registered direct offering of common stock Announced: about US$4.7M · US$9.25 a share · Dawson James Securities, Inc. Dealers: Dawson James Securities, Inc. (lead) Use of proceeds: Market development and clinical evidence, product development and quality, general and administration support, and general corporate purposes | Jan 30, 2025 |
| Public offering of common stock and pre-funded warrants with series A and series B common warrants Closed: US$14.4M raised · US$0.1 a share · Warrants at US$0.2 · Dawson James Securities, Inc. Dealers: Dawson James Securities, Inc. (lead) Use of proceeds: Redeem all outstanding Series B Preferred Stock; build out product platforms, expand sales and marketing, G&A and general corporate purposes | Jan 17, 2025 |
Open Financings · Read by 6ix AI from the company's releases
IPO
Priced at US$4.35 a unit on Apr 21, 2022.
- Price
- US$4.35 a unit
- Units offered
- 2,165,000 units
- Offering size
- US$9.4 million
- Underwriters' option
- Up to 324,750 more units
- Listing
- ACON on the Nasdaq Capital Market
- Underwriter
- Maxim Group LLC
- Units delivered
- On or about Apr 26, 2022
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Oct 25, 2021 |
| Filed publicly | Jan 6, 2022 |
| Amended 5 times | Newest Apr 20, 2022 |
| Shares registered with an exchange | Apr 20, 2022 |
| Declared effective by the SEC | Apr 21, 2022 |
| Final prospectus, with the price | Apr 25, 2022 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Apr 25, 2022 |
| EFFECT · Notice that a registration is effective | Apr 21, 2022 |
| CERT · Exchange's certificate of listing | Apr 21, 2022 |
| 8-A12B · Registration of shares for listing on an exchange | Apr 20, 2022 |
| CORRESP · Letter to the SEC | Apr 20, 2022 |
| CORRESP · Letter to the SEC | Apr 20, 2022 |
| CORRESP · Letter to the SEC | Apr 20, 2022 |
| S-1/A · Registration statement, amended | Apr 20, 2022 |
| S-1/A · Registration statement, amended | Apr 19, 2022 |
| CORRESP · Letter to the SEC | Apr 1, 2022 |
All 21 filings
| Filing | Filed |
|---|---|
| S-1/A · Registration statement, amended | Apr 1, 2022 |
| CORRESP · Letter to the SEC | Mar 23, 2022 |
| S-1/A · Registration statement, amended | Mar 23, 2022 |
| UPLOAD · Letter from the SEC | Mar 15, 2022 |
| CORRESP · Letter to the SEC | Mar 4, 2022 |
| S-1/A · Registration statement, amended | Mar 4, 2022 |
| UPLOAD · Letter from the SEC | Jan 26, 2022 |
| S-1 · Registration statement | Jan 6, 2022 |
| CORRESP · Letter to the SEC | Jan 5, 2022 |
| UPLOAD · Letter from the SEC | Nov 30, 2021 |
| DRS · Draft registration statement | Oct 25, 2021 |
Open IPO · From the cover of the final prospectus (424B4) filed Apr 25, 2022
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 75.7K | 45.7K | 75.4K | 60.4K | 60.3K | 48.7K | 26.9K |
| Cost of revenue | 68.9K | 84.7K | 75.7K | 65.3K | 69.2K | 66.2K | 63.2K |
| Gross profit | 6.83K | -38.9K | -324 | -4.85K | -8.88K | -17.6K | -36.3K |
| Research and development | 1.03M | 888.8K | 873.3K | 1.07M | 787.9K | 1.05M | 1.74M |
| Selling, general and administrative | 4.12T | 3.61M | 3.25M | 3.99M | 1.83M | 1.07M | 1.59M |
| Operating income | -7.05M | -5.51M | -4.88M | -5.56M | -2.95M | -4.48M | -4.01M |
| Depreciation and amortization | 227.4K | 193.1K | 162.7K | 143.6K | 186.4K | 196.3K | 178.2K |
| EBITDA | -6.82M | -5.32M | -4.71M | -5.42M | -2.77M | -4.28M | -3.84M |
| Interest expense | 0 | 64.1K | 110.5K | 1.51M | 474.9K | 156.1K | 5.00K |
| Income before tax | -7.23M | -6.99M | -4.91M | -7.07M | -4.95M | -4.64M | -4.02M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 155.1K | 4.83K |
| Net income | -7.23M | -6.99M | -4.91M | -7.07M | -4.95M | -4.64M | -4.02M |
| Earnings per share, basic | -13.61 | -7,478.90 | -79,782.00 | -19.61 | -6.58 | ||
| Earnings per share, diluted | -13.61 | -7,478.90 | -79,782.00 | -19.61 | -6.58 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 12.0M | 453.7K | 1.02M | 1.47M | 432.5K | 15.0K | 128.2K |
| Short-term investments | 39.0K | ||||||
| Receivables | 29.7K | 18.3K | 13.3K | 18.6K | 6.28K | 22.5K | 14.7K |
| Inventory | 1 | 301.3K | 1 | ||||
| Current assets | 12.4M | 824.3K | 1.29M | 1.70M | 732.2K | 97.1K | 218.5K |
| Property, plant and equipment | 24.2K | 5.50K | 1.78K | 3.35K | 12.6K | 25.6K | 48.5K |
| Total assets | 13.7M | 2.12M | 2.46M | 2.91M | 1.89M | 1.29M | 1.43M |
| Accounts payable | 333.0K | 531.6K | 760.5K | 462.2K | 1.07M | 859.5K | 501.0K |
| Current liabilities | 837.3K | 1.15M | 3.19M | 688.7K | 7.62M | 8.38M | 3.13M |
| Total debt | 1.13M | 4.64K | 2.00M | 2.38M | 515.6K | ||
| Total liabilities | 837.3K | 1.15M | 3.19M | 688.7K | 7.62M | 8.38M | 3.13M |
| Shareholders' equity | 12.8M | 970.1K | -728.0K | 2.23M | -12.8M | -7.08M | -1.70M |
| Shares outstanding | 854.4K | 1.37K | 825.5K | 491.3K | 905.7K | 50 | 50 |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -7.16M | -5.27M | -3.65M | -4.95M | -2.40M | -1.79M | -4.17M |
| Capital spending | -21.5K | -5.12K | 0 | -208.9K | -1 | -179.0K | -267.2K |
| Free cash flow | -7.19M | -5.28M | -3.65M | -5.52M | -2.35M | -1.97M | -4.44M |
| Cash from investing | -203.9K | -321.9K | -119.5K | -207.9K | -102.0K | -179.0K | -267.2K |
| Cash from financing | 18.9M | 5.03M | 3.31M | 6.19M | 2.94M | 1.86M | 2.95M |
| Dividends paid | -5.42B | -59.7K | -415.5K | ||||
| Share buybacks | -1.21M | 0 | -1.00K | 0 | -60.4K | ||
| Change in cash | 11.6M | -567.4K | -451.7K | 1.03M | 437.5K | -113.2K | -1.49M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 20, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 5, 2026 | Quarterly report | SEC |
| 4 · Change in ownership | Aug 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 17, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 6, 2026 | Quarterly report | SEC |
| S-8 · Registration statement for employee plans | Jul 9, 2026 | Offer document | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Jun 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2026 | Insider trade | SEC |
| 8-K · Current report | Jun 4, 2026 | Meeting outcome | SEC |
| 10-Q · Quarterly report | May 13, 2026 | Quarterly report | SEC |
| 4 · Change in ownership | May 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 8, 2026 | Insider trade | SEC |
| DEF 14A · Proxy statement | Apr 27, 2026 | Meeting notice | SEC |
| 8-K · Current report | Apr 22, 2026 | Current report | SEC |
| PRE 14A · Preliminary proxy statement | Apr 3, 2026 | Meeting notice | SEC |
| SCHEDULE 13G · Big-stake notice | Mar 25, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Mar 19, 2026 | Material contract | SEC |
| 8-A12B · Registration of shares for listing on an exchange | Mar 19, 2026 | Other filings | SEC |
| 10-K · Annual report | Mar 18, 2026 | Annual report | SEC |
| 8-K · Current report | Jan 13, 2026 | Current report | SEC |
| 8-K · Current report | Jan 9, 2026 | Material contract | SEC |
| 424B5 · Prospectus | Jan 9, 2026 | Offer document | SEC |
| 4 · Change in ownership | Dec 1, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 12, 2025 | Quarterly report | SEC |
| 8-K · Current report | Oct 14, 2025 | Material contract | SEC |
| 424B5 · Prospectus | Oct 14, 2025 | Offer document | SEC |
| 4 · Change in ownership | Sep 3, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 3, 2025 | Insider trade | SEC |
| 8-K · Current report | Sep 3, 2025 | Material contract | SEC |
| 10-Q · Quarterly report | Aug 14, 2025 | Quarterly report | SEC |
| 8-K · Current report | Jul 21, 2025 | Meeting outcome | SEC |
| DEFA14A · Additional proxy material | Jul 7, 2025 | Meeting notice | SEC |
| 8-K · Current report | Jul 7, 2025 | Meeting outcome | SEC |
| 8-K · Current report | Jun 20, 2025 | Management or board change | SEC |
| 10-Q · Quarterly report | May 15, 2025 | Quarterly report | SEC |
| DEF 14A · Proxy statement | May 12, 2025 | Meeting notice | SEC |
| EFFECT · Notice that a registration is effective | May 6, 2025 | Other filings | SEC |
| PRE 14A · Preliminary proxy statement | May 2, 2025 | Meeting notice | SEC |
| CORRESP · Letter to the SEC | Apr 30, 2025 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Apr 29, 2025 | Other filings | SEC |
| S-3 · Registration statement | Apr 25, 2025 | Offer document | SEC |
| 8-K · Current report | Apr 23, 2025 | Current report | SEC |
| 10-K · Annual report | Apr 8, 2025 | Annual report | SEC |
| NT 10-K · Late filing notice | Mar 31, 2025 | Explanation request | SEC |
| 8-K · Current report | Mar 28, 2025 | Current report | SEC |
| 8-K · Current report | Mar 13, 2025 | Current report | SEC |
| 8-K · Current report | Mar 6, 2025 | Meeting outcome | SEC |
| 8-K · Current report | Feb 28, 2025 | Meeting outcome | SEC |
| DEFA14A · Additional proxy material | Feb 28, 2025 | Meeting notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 13, 2025 | Big-stake notice | SEC |
| DEF 14A · Proxy statement | Feb 3, 2025 | Meeting notice | SEC |
| 8-K · Current report | Jan 31, 2025 | Material contract | SEC |
| 424B5 · Prospectus | Jan 31, 2025 | Offer document | SEC |
| 8-K · Current report | Jan 30, 2025 | Current report | SEC |
| PRE 14A · Preliminary proxy statement | Jan 22, 2025 | Meeting notice | SEC |
| SCHEDULE 13G · Big-stake notice | Jan 21, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Jan 17, 2025 | Material contract | SEC |
| 424B4 · Prospectus | Jan 16, 2025 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Jan 15, 2025 | Other filings | SEC |
| S-1MEF · Registration of more shares for the same offering | Jan 14, 2025 | Offer document | SEC |
| CORRESP · Letter to the SEC | Jan 10, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jan 10, 2025 | Other filings | SEC |
| S-1/A · Registration statement, amended | Jan 10, 2025 | Offer document | SEC |
| 8-K · Current report | Jan 6, 2025 | Material contract | SEC |
| 424B5 · Prospectus | Jan 6, 2025 | Offer document | SEC |
| 8-K · Current report | Jan 3, 2025 | Current report | SEC |
| 8-K · Current report | Jan 3, 2025 | Meeting outcome | SEC |
| S-1/A · Registration statement, amended | Dec 26, 2024 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Dec 16, 2024 | Other filings | SEC |
| S-1 · Registration statement | Dec 11, 2024 | Offer document | SEC |
| DEF 14A · Proxy statement | Dec 2, 2024 | Meeting notice | SEC |
| 8-K · Current report | Nov 27, 2024 | Material contract | SEC |
| PRE 14A · Preliminary proxy statement | Nov 22, 2024 | Meeting notice | SEC |
| 10-Q · Quarterly report | Nov 14, 2024 | Quarterly report | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 13, 2024 | Big-stake notice | SEC |
| EFFECT · Notice that a registration is effective | Nov 12, 2024 | Other filings | SEC |
| 424B3 · Prospectus | Nov 8, 2024 | Offer document | SEC |
| CORRESP · Letter to the SEC | Nov 7, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Nov 7, 2024 | Other filings | SEC |
| 424B3 · Prospectus | Nov 5, 2024 | Offer document | SEC |
| 424B3 · Prospectus | Nov 5, 2024 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Nov 5, 2024 | Other filings | SEC |
| S-3 · Registration statement | Nov 4, 2024 | Offer document | SEC |
| CORRESP · Letter to the SEC | Nov 1, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Nov 1, 2024 | Other filings | SEC |
| S-1 · Registration statement | Oct 25, 2024 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Oct 25, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Oct 18, 2024 | Other filings | SEC |
| D | Oct 15, 2024 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Oct 11, 2024 | Offer document | SEC |
| 8-K · Current report | Oct 11, 2024 | Current report | SEC |
| 8-K · Current report | Oct 1, 2024 | Material contract | SEC |
| 8-K · Current report | Sep 24, 2024 | Material contract | SEC |
| 424B5 · Prospectus | Sep 24, 2024 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Sep 24, 2024 | Other filings | SEC |
| 8-K · Current report | Sep 23, 2024 | Meeting outcome | SEC |
| CORRESP · Letter to the SEC | Sep 20, 2024 | Other filings | SEC |
| S-3/A · Registration statement, amended | Sep 19, 2024 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Sep 16, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Sep 16, 2024 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Sep 6, 2024 | Offer document | SEC |
| S-3 · Registration statement | Sep 6, 2024 | Offer document | SEC |
| SC 13G · Big-stake notice | Sep 5, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Aug 29, 2024 | Material contract | SEC |
| DEF 14A · Proxy statement | Aug 26, 2024 | Meeting notice | SEC |
| 8-K · Current report | Aug 23, 2024 | Current report | SEC |
| 8-K · Current report | Aug 16, 2024 | Material contract | SEC |
| PRE 14A · Preliminary proxy statement | Aug 16, 2024 | Meeting notice | SEC |
| 10-Q · Quarterly report | Aug 14, 2024 | Quarterly report | SEC |
| 253G3 | Aug 13, 2024 | Other filings | SEC |
| 8-K/A · Current report, amended | Aug 13, 2024 | Material contract | SEC |
| 8-K · Current report | Aug 12, 2024 | Material contract | SEC |
| 8-K · Current report | Jun 26, 2024 | Material contract | SEC |
| QUALIF | Jun 25, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jun 20, 2024 | Other filings | SEC |
| 1-A/A | Jun 20, 2024 | Other filings | SEC |
| 8-K · Current report | Jun 18, 2024 | Current report | SEC |
| UPLOAD · Letter from the SEC | Jun 17, 2024 | Other filings | SEC |
| 1-A | Jun 10, 2024 | Other filings | SEC |
| 10-Q · Quarterly report | May 15, 2024 | Quarterly report | SEC |
| 8-K · Current report | Apr 29, 2024 | Current report | SEC |
| 8-K · Current report | Apr 12, 2024 | Current report | SEC |
| SC 13G/A · Big-stake notice, amended | Mar 29, 2024 | Big-stake notice | SEC |
| 10-K · Annual report | Mar 28, 2024 | Annual report | SEC |
| SC 13G · Big-stake notice | Mar 6, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Feb 27, 2024 | Material contract | SEC |
| 424B4 · Prospectus | Feb 27, 2024 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Feb 27, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Feb 23, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Feb 23, 2024 | Other filings | SEC |
| S-1/A · Registration statement, amended | Feb 23, 2024 | Offer document | SEC |
| 8-K · Current report | Feb 21, 2024 | Results | SEC |
| S-1/A · Registration statement, amended | Feb 21, 2024 | Offer document | SEC |
| S-1/A · Registration statement, amended | Feb 6, 2024 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Feb 2, 2024 | Other filings | SEC |
| 424B3 · Prospectus | Feb 1, 2024 | Offer document | SEC |
| CORRESP · Letter to the SEC | Feb 1, 2024 | Other filings | SEC |
| S-1/A · Registration statement, amended | Jan 31, 2024 | Offer document | SEC |
| 8-K · Current report | Jan 29, 2024 | Material contract | SEC |
| UPLOAD · Letter from the SEC | Jan 26, 2024 | Other filings | SEC |
| 8-K · Current report | Jan 23, 2024 | Material contract | SEC |
| S-1 · Registration statement | Jan 22, 2024 | Offer document | SEC |
| SC 13G · Big-stake notice | Jan 12, 2024 | Big-stake notice | SEC |
| 424B3 · Prospectus | Jan 4, 2024 | Offer document | SEC |
| 8-K · Current report | Jan 4, 2024 | Current report | SEC |
| SC 13G/A · Big-stake notice, amended | Dec 29, 2023 | Big-stake notice | SEC |
| UPLOAD · Letter from the SEC | Dec 20, 2023 | Other filings | SEC |
| 8-K · Current report | Dec 19, 2023 | Meeting outcome | SEC |
| S-1 · Registration statement | Dec 11, 2023 | Offer document | SEC |
| 8-K · Current report | Nov 22, 2023 | Material contract | SEC |
| 424B3 · Prospectus | Nov 16, 2023 | Offer document | SEC |
| 10-Q · Quarterly report | Nov 14, 2023 | Quarterly report | SEC |
| DEF 14A · Proxy statement | Nov 13, 2023 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Nov 1, 2023 | Meeting notice | SEC |
| SC 13G · Big-stake notice | Oct 30, 2023 | Big-stake notice | SEC |
| 424B3 · Prospectus | Oct 23, 2023 | Offer document | SEC |
| 424B3 · Prospectus | Oct 23, 2023 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Oct 23, 2023 | Other filings | SEC |
| S-1/A · Registration statement, amended | Oct 20, 2023 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Oct 19, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Oct 18, 2023 | Other filings | SEC |
| S-1 · Registration statement | Oct 10, 2023 | Offer document | SEC |
| 8-K · Current report | Oct 10, 2023 | Material contract | SEC |
| 8-K · Current report | Sep 28, 2023 | Current report | SEC |
| 8-K · Current report | Sep 7, 2023 | Current report | SEC |
| 8-K · Current report | Sep 1, 2023 | Material contract | SEC |
| 8-K · Current report | Aug 31, 2023 | Current report | SEC |
| 8-K · Current report | Aug 25, 2023 | Results | SEC |
| 10-Q · Quarterly report | Aug 25, 2023 | Quarterly report | SEC |
| 8-K · Current report | Aug 14, 2023 | Material contract | SEC |
| NT 10-Q · Late filing notice | Aug 14, 2023 | Explanation request | SEC |
| 8-K · Current report | Aug 10, 2023 | Current report | SEC |
| EFFECT · Notice that a registration is effective | Jul 17, 2023 | Other filings | SEC |
| 8-K · Current report | Jul 14, 2023 | Current report | SEC |
| 424B3 · Prospectus | Jul 14, 2023 | Offer document | SEC |
| CORRESP · Letter to the SEC | Jul 13, 2023 | Other filings | SEC |
| S-1/A · Registration statement, amended | Jul 12, 2023 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Jul 11, 2023 | Other filings | SEC |
| 8-K · Current report | Jul 7, 2023 | Current report | SEC |
| S-1 · Registration statement | Jul 3, 2023 | Offer document | SEC |
| 10-Q · Quarterly report | Jul 3, 2023 | Quarterly report | SEC |
| 8-K · Current report | Jun 20, 2023 | Current report | SEC |
| 10-K/A · Annual report, amended | Jun 12, 2023 | Annual report | SEC |
| D | May 31, 2023 | Other filings | SEC |
| 8-K · Current report | May 30, 2023 | Current report | SEC |
| 8-K · Current report | May 23, 2023 | Results | SEC |
| 8-K · Current report | May 17, 2023 | Material contract | SEC |
This page holds 200 of 277 filings. Open Filings
Cap table
Built by 6ix from Aclarion, Inc.’s releases · as of Jan 13, 2026
- Common shares
- 2,882,371
- Fully diluted
- 2,982,371
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 2,882,371 | |
| Warrants | 100,000 | Jan 16, 2025 |
Warrants and options
| Lot |
|---|
| Warrants · US$0.20 · expiry not stated |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 2,882,371 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Gregory A Gould Other companies: Charlotte's Web Holdings, Inc. (Chief Financial Officer · Jun 17, 2022 – Jun 20, 2022 · Past); Newage Inc (Chief Financial Officer · Oct 8, 2018 – Jul 2, 2021 · Past); Aytu BioPharma, Inc. (Chief Financial Officer · Apr 16, 2015 – Mar 16, 2017 · Past); Ampio Pharmaceuticals, Inc. (Chief Financial Officer · Jun 10, 2014 – Jul 15, 2016 · Past); SeraCare Life Sciences Inc (Interim CEO, CFO, Treas & Sec. · Aug 16, 2006 – Apr 20, 2012 · Past); CytoDyn Inc. (Director · Mar 20, 2006 – Jun 18, 2019 · Past) | CFO · Since at least Sep 2, 2025 |
| Stephen Deitsch Other companies: Auddia Inc. (Director · Feb 16, 2024 – Feb 16, 2025 · Past); Paragon 28 Inc (Chief Financial Officer · Oct 21, 2023 – Mar 8, 2024 · Past) | Director · Since at least Jun 11, 2026 |
| Greg Gould Other companies: Charlotte's Web Holdings, Inc. (Chief Financial Officer · Sep 3, 2025 – Nov 4, 2026 · Past) | Chief Financial Officer · Since at least Apr 22, 2026 |
| Jeffrey John Thramann Other companies: Auddia Inc. (CEO and Executive Chairman, Director · Since at least Feb 16, 2021) | Executive Chairman, Director · Since at least Apr 21, 2022 |
| William Wesemann Other companies: LivePerson, Inc. (Director · Since at least May 7, 2019) | Director · Since at least Apr 21, 2022 |
| Amanda Williams | SVP, Clinical and Regulatory at Cordis · Since at least Apr 21, 2022 |
| Bill Wesemann | Director, LivePerson Inc., Stationhead Inc., Mylio Inc. · Since at least Aug 17, 2026 |
| Brent Ness | Chief Executive Officer, President, and Director · Since at least Apr 21, 2022 |
| Daniel Keefe | Commercial Director, Western U · Since at least Apr 28, 2026 |
| Dan Isherwood | UK Commercial Director · Nov 5, 2025 – Nov 5, 2026 · Past |
All 16 people
| Person | Seat |
|---|---|
| David K Neal | Director · Since at least Apr 21, 2022 |
| Jason Brosniak | Commercial Director · Since at least Dec 2, 2025 |
| Jeff Thramann | Executive Director, Executive Chairman, and Director · Since at least Jun 10, 2026 |
| John Paul Lorbiecki | Chief Financial Officer · Apr 21, 2022 – Dec 29, 2022 · Past |
| Ryan Bond | Chief Strategy Officer · Since at least Apr 21, 2022 |
| Scott Breidbart | Director · Since at least Apr 21, 2022 |
Log in to ask 6ix AI your own questions about Aclarion, Inc.